Acting on it

What you can do with this research, and what we are not allowed to do for you.

Read this first

People read research and want to act on it — that is why it is published. But the line between publishing a view and advising a person is a legal one, and this firm sits firmly on the publishing side of it.

Limit 1: Substrata publishes research. It does not manage money, hold client assets, execute orders, or take a position in anything it covers.
Limit 2: Everything here is a general view, published to whoever reads it. It is not addressed to you, and it takes no account of your circumstances.
Limit 3: Substrata is paid nothing by any participant in this directory. If that ever changes it will be written here before the arrangement starts.

Listed equity in the chain

Exposure to the listed producers, tool makers and refiners that appear in the map — the most accessible route, and the only one most readers will need.

Who provides it: Any regulated broker or bank offering international market access.
What it does not give you: Many of the most concentrated nodes are private, family-held, or listed only domestically in markets a retail account cannot reach. And a listed company is rarely a pure play on the chokepoint you care about; the interesting segment is often a small share of its revenue.
Worth asking: Which exchanges can this account actually reach, and at what cost? · What share of this company’s revenue comes from the segment the research is about? · Is there a foreign-ownership limit or a withholding treatment I should know about?

Exchange-traded commodity exposure

Liquid, transparent exposure to the benchmark grade of a traded metal.

Who provides it: Brokers offering futures, or issuers of exchange-traded commodities.
What it does not give you: The benchmark grade is almost never the grade this research is about. Exchange tin is not seven-nines tin qualified for an EUV source, and the premium between them is the part that reflects the chokepoint. Rolling a futures position also carries a cost that has nothing to do with the thesis.
Worth asking: What exactly does this contract deliver — which grade, which warehouse? · What has the roll cost been over a horizon like mine? · Is the premium I actually care about visible in this price at all?

Physical metal

The only route that touches the actual grade — and, for an industrial buyer, the one that also solves a supply problem rather than expressing a view.

Who provides it: Specialist metals dealers and vaulting or custody providers.
What it does not give you: Liquidity. Assay, storage, insurance, minimum lot sizes and a bid-offer that reflects a genuinely thin market. Several of these materials are export-controlled, which is a licensing question before it is a price question.
Worth asking: What assay and certificate of analysis comes with the lot, and from whom? · Where is it stored, insured by whom, and what does it cost to hold per year? · Who will buy this back from me, and at what discount to today’s price?

Private markets

Access to the part of the universe that is not listed anywhere — which, for several chokepoints in the map, is the only part there is.

Who provides it: Licensed placement agents, private funds, and eligibility-gated platforms.
What it does not give you: Liquidity, price discovery, or entry on your timetable. Eligibility rules (qualified, professional or accredited investor, depending on jurisdiction) exclude most people by law, not by preference.
Worth asking: Am I eligible for this under my own jurisdiction’s rules — and who verified that? · Is the party introducing this licensed to do so, and how are they paid? · What is the realistic holding period before any liquidity event?

Thematic funds

Diversified, professionally managed exposure without needing to pick nodes.

Who provides it: Fund managers and the platforms that distribute them.
What it does not give you: Precision. A fund named for a theme frequently holds the visible layer — the large, liquid, widely-owned names — rather than the constrained one. The holdings list settles this in about five minutes, and it is worth the five minutes.
Worth asking: What are the actual top holdings, and do they own the chokepoint or sit next to it? · What is the total cost of ownership, including anything not in the headline fee?

Securing supply instead of buying exposure

For a company that consumes any of this, the highest-return action is usually not an investment at all: qualify a second source, lengthen a contract, or hold strategic stock before the constraint binds. The map is a supplier list as much as it is a research product.

Who provides it: Your own procurement function, and the producers in the map directly.
What it does not give you: Anything financial. This is an operational decision with operational costs — qualification time, working capital, obsolescence risk.
Worth asking: Which of these producers is already qualified for our process, and which is not? · What would a second source cost in time, not just in price?

What we can do if you get in touch

We can answer questions about the research: why a node is in the universe, what a grade designation means, who else makes something, what we have and have not verified. We are glad to be told a row is wrong, and that is the most useful message anyone sends us.

We cannot tell you what to buy, how much, or when. Not because of caution but because doing so would be a licensed activity we are not licensed for, and a firm that quietly crosses that line has told you exactly how much its other statements are worth.

Becoming the investor

Requirements met to manage money rather than only publish11%

1 / 9

1 done, 2 in progress. Managing third-party money is licensed activity everywhere that matters, and the gap below is real rather than paperwork. It is published for the same reason the coverage meter is: a plan with statuses is a plan, and everything else is a feeling.

The ledger

A written, public investment thesis — Done: Stated above, with a falsifier against each claim, so it can be scored rather than admired.
A documented research process and coverage universe — In progress: Two tests, a defined universe, and a verification standard that separates leads from findings. Phase 1 is not finished; the meter on the map says by how much.
Conflicts, personal-dealing and disclosure policy — In progress: The disclosure rules are written and public. Personal-dealing rules for staff, and the compliance function to enforce them, are not.
A timestamped, independently checkable track record — Not started: The single hardest one to fake and the slowest to acquire. It starts accruing the day published calls carry dates nobody can quietly edit.
Legal entity, domicile and governance — Not started: Structure follows the regulatory pathway, so it waits on the next line.
Regulatory pathway chosen and licence obtained — Not started: Managing third-party money is licensed activity. The options — an asset-manager licence, operating under a licensed manager, or a structure that stays below a threshold — have materially different costs and timelines, and none is quick.
Investor eligibility, KYC and AML onboarding — Not started: Eligibility is a legal test, not a checkbox. This is also where the portal stops being an account and starts being a regulated record.
Custody, execution and administration relationships — Not started: Somebody independent has to hold the assets and strike the valuations.
Valuation and investor reporting policy — Not started: How positions are marked, how often, and by whom — agreed before the first one.